http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2009010034-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2008-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_879a8a0558f0721d3cd5f05361dafa88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d42f014dd782a8548c123d1bb62b4e01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f58d54a70feaef466dcad88b66781474
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc3862368438bc207621a3b33a1f02e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8127aae89225ba512692b270e73c50d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e230ed0bfefb4466ee4516dd4343315
publicationDate 2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2009010034-A
titleOfInvention PYRIMIDODIAZEPINAS REPLACED USEFUL INHIBITORS OF THE PLK1.
abstract The present invention provides PLK1 inhibitor compounds of the formula (I): (see formula (I)) They are useful for the treatment or control of cell proliferation disorders, in particular oncological disorders. These compounds and the formulations containing them may be useful for the treatment or control of solid tumors, for example, breast, colon, lung or prostate tumors and other oncological disorders, for example non-Hodgkin lymphomas.
priorityDate 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67119549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410538493

Total number of triples: 28.